Skip to content
Register Sign in Wishlist

Pharmacogenetics of Psychotropic Drugs

Bernard Lerer, Anil K. Malhotra, Thomas A. Ban, Sheldon H. Preskorn, Fabio Macciardi, K. Peter Lesch, Jens Benninghoff, Angelika Schmitt, Colleen M. Niswender, Linda K. Hutchinson, Vural Ozdemir, Angelea D. M. Kashuba, Vincenzo S. Basile, James L. Kennedy, Pierre Baumann, Chin B. Eap, David A. Collier, Maria J. Arranz, Sarah Osborne, Katherine J. Aitchison, Janet Munro, Dalu Mancama, Robert W. Kerwin, Ronnen H. Segman, Bernard Lerer, Marco Catalano, Emanuela Mundo, Smita A. Pandit, Spilios V. Argyropoulos, Patrick G. Kehoe, David J. Nutt, Martin Alda, Tom N. Ferraro, Keith Schappert, Pierre Sevigny, Judes Poirier, Joel Gelernter, Henry Kranzler, Steven G. Potkin, Anne Shalom, Ariel Darvasi, William Z. Potter, AnnCatherine Van Lone, Larry Altstiel
View all contributors
  • Date Published: April 2011
  • availability: Available
  • format: Paperback
  • isbn: 9780521189613

Paperback

Add to wishlist

Other available formats:
Hardback, eBook


Looking for an inspection copy?

Please email [email protected] to enquire about an inspection copy of this book

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Pharmacogenetics and pharmacogenomics are areas of significant importance at the interface of molecular genetics and psychopharmacology, with implications for drug development and clinical practice. This 2002 book provides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the established findings. Coverage extends to antipsychotics, antidepressants, mood stabilising, cognitive-enhancing and anxiolytic drugs. Chapters also examine the interface of pharmacogenetics with substance dependence and brain imaging, and consider its impact on the biotechnology and pharmaceutical industries. This book defines the young field of pharmacogenetics as it applies to psychotropic drugs, and is therefore of interest to all clinicians and researchers working in this field.

    • Was the first book to survey the new field of pharmacogenetics as applied to psychotropics
    • Editor and contributors at the forefront of the field
    • Covers all the main classes of psychotropic drugs, with implications for drug development and clinical practice
    Read more

    Reviews & endorsements

    Review of the hardback: '… this is a well-written book on a subject which is often found complicated and difficult … the book will be informative for the reader who wants a general review of the field of psychopharmacogenetics, but will also be useful for the reader who wants updated information on a specific topic …' European Journal of Clinical Pharmacology

    Review of the hardback: 'This book gives a comprehensive review of the current state of the art covering almost all aspects of psychiatric pharmacogenetics. It provides an excellent introduction to the newcomer in this field and at the same time it is a most valuable source of information also for the experts.' Acta Psychiatrica Scandinavica

    Review of the hardback: 'Bernard Lerer is to be congratulated in bringing together a group of authors who have presented an excellent, yet concise, overview of the importance of pharmacogenetics in contemporary psychopharmacology. … this monograph is recommended to all those wishing to keep abreast of this important area of neuroscience.' Human Psychopharmacology

    See more reviews

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: April 2011
    • format: Paperback
    • isbn: 9780521189613
    • length: 460 pages
    • dimensions: 244 x 170 x 24 mm
    • weight: 0.73kg
    • availability: Available
  • Table of Contents

    Part I. Introduction:
    1. Genes and psychopharmacology: exploring the interface Bernard Lerer
    Part II. Clinical Background and Research Design:
    2. From pharmacogenetics to pharmacogenomics of psychotropic drug response Anil K. Malhotra
    3. Neuropsychopharmacology: the interface between genes and psychiatric nosology Thomas A. Ban
    4. Methodological issues in psychopharmacogenetics Sheldon H. Preskorn
    5. Statistical approaches in psychopharmacogenetics Fabio Macciardi
    Part III. Molecular Background:
    6. The psychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways K. Peter Lesch, Jens Benninghoff and Angelika Schmitt
    7. RNA processing regulation and interindividual variation Colleen M. Niswender and Linda K. Hutchinson
    Part IV. Pharmacokinetics:
    8. Pharmacogenetics of psychotropic drug metabolism Vural Ozdemir, Angela D. M. Kashuba, Vincenzo S. Basile and James L . Kennedy
    9. Pharmacogenetics of chiral psychotropic drugs Pierre Baumann and Chin B. Eap
    Part V. Specific Psychotropic Drugs and Disorders:
    10. Clozapine response and genetic variation in neurotransmitter receptor targets David A. Collier, Maria J. Arranz, Sarah Osborne, Katherine J. Aitchison, Janet Munro, Dalu Mancama and Robert W. Kerwin
    11. Genetic factors underlying drug-induced tardive dyskinesia Ronnen H. Segman and Bernard Lerer
    12. Functional gene-linked polymorphic regions in pharmacogenetics Marco Catalano
    13. Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders Emanuela Mundo and James L. Kennedy
    14. Pharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex Smita A. Pandit, Spilios V. Argyropoulous, Patrick G. Kehoe and David J. Nutt
    15. Genetic factors and long-term prophylaxis in bipolar disorder Martin Alda
    16. Genetic influences on responsiveness to anticonvulsant drugs Thomas N. Ferraro
    17. Apolipoprotein E as a marker in the treatment of Alzheimer's disease Keith Schappert, Pierre Sevigny and Judes Poirier
    18. Genetic variation and drug dependence risk factors Joel Gelernter and Henry Kranzler
    Part VI. Pharmacogenetics and Brain Imaging:
    19. Brain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia Steven G. Potkin, James L. Kennedy and Vincenzo S. Basile
    Part VII. Industry perspectives:
    20. Pharmacogenetics in psychotropic drug discovery and development William Z. Potter, AnnCatherine Van Lone and Larry Altstiel
    21. High-throughput single nucleotide polymorphism genotyping Anne Shalom and Ariel Darvasi
    Index.

  • Resources for

    Pharmacogenetics of Psychotropic Drugs

    General Resources

    Find resources associated with this title

    Type Name Unlocked * Format Size

    Showing of

    Back to top

    This title is supported by one or more locked resources. Access to locked resources is granted exclusively by Cambridge University Press to lecturers whose faculty status has been verified. To gain access to locked resources, lecturers should sign in to or register for a Cambridge user account.

    Please use locked resources responsibly and exercise your professional discretion when choosing how you share these materials with your students. Other lecturers may wish to use locked resources for assessment purposes and their usefulness is undermined when the source files (for example, solution manuals or test banks) are shared online or via social networks.

    Supplementary resources are subject to copyright. Lecturers are permitted to view, print or download these resources for use in their teaching, but may not change them or use them for commercial gain.

    If you are having problems accessing these resources please contact [email protected].

  • Editor

    Bernard Lerer, Hadassah-Hebrew Medical Center, Jerusalem

    Contributors

    Bernard Lerer, Anil K. Malhotra, Thomas A. Ban, Sheldon H. Preskorn, Fabio Macciardi, K. Peter Lesch, Jens Benninghoff, Angelika Schmitt, Colleen M. Niswender, Linda K. Hutchinson, Vural Ozdemir, Angelea D. M. Kashuba, Vincenzo S. Basile, James L. Kennedy, Pierre Baumann, Chin B. Eap, David A. Collier, Maria J. Arranz, Sarah Osborne, Katherine J. Aitchison, Janet Munro, Dalu Mancama, Robert W. Kerwin, Ronnen H. Segman, Bernard Lerer, Marco Catalano, Emanuela Mundo, Smita A. Pandit, Spilios V. Argyropoulos, Patrick G. Kehoe, David J. Nutt, Martin Alda, Tom N. Ferraro, Keith Schappert, Pierre Sevigny, Judes Poirier, Joel Gelernter, Henry Kranzler, Steven G. Potkin, Anne Shalom, Ariel Darvasi, William Z. Potter, AnnCatherine Van Lone, Larry Altstiel

also by this author

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email [email protected]

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×
warning icon

Turn stock notifications on?

You must be signed in to your Cambridge account to turn product stock notifications on or off.

Sign in Create a Cambridge account arrow icon
×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×